Laurion Capital Management LP Cyteir Therapeutics, Inc. Transaction History

Laurion Capital Management LP

  • $7.27 Billion
  • Q3 2024

Shares

2 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q4 2023

Feb 14, 2024
SELL
$2.84 - $3.13 $122,969 - $135,525
-43,299 Reduced 12.04%
316,201 $961,000
Q2 2022

Aug 15, 2022
BUY
$1.62 - $4.4 $582,390 - $1.58 Million
359,500 New
359,500 $1.08 Million

Others Institutions Holding CYT

# of Institutions
2
Shares Held
2.47M
Call Options Held
0
Put Options Held
0
View Full List

About Cyteir Therapeutics, Inc.

CYT Quotes by TradingView
  • Ticker CYT
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 35,413,400
  • Market Cap $107M
  • Description
  • Cyteir Therapeutics, Inc., a clinical-stage biotechnology company, develops and commercializes the next-generation of precision oncology medicines. Its lead product CYT-0851, a novel, oral, once-daily, small molecule drug candidate that is in Phase I/II clinical trial for monotherapy in solid tumors and hematologic malignancies, as well as for c...
More about CYT
Track This Portfolio

Track Laurion Capital Management LP Portfolio

Follow Laurion Capital Management LP and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Laurion Capital Management LP, based on Form 13F filings with the SEC.

News

Stay updated on Laurion Capital Management LP with notifications on news.

Choose your preferred platform and Sign Up 👇 Telegram Email